Visualization of the relationship between fungi and cancer from the perspective of bibliometric analysis.

Anticancer Bibliometric analysis Cancer Fungal metabolites Fungi

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 18 04 2023
revised: 20 07 2023
accepted: 21 07 2023
medline: 2 8 2023
pubmed: 2 8 2023
entrez: 2 8 2023
Statut: epublish

Résumé

The relationship between cancer and microorganisms has been extensively studied, with bacteria receiving more attention than fungi. However, fungi have been shown to play a significant role in cancer development and progression. Understanding the underlying mechanisms is crucial for identifying new avenues in prevention and treatment. To evaluate the current state of research on fungi and cancer, we conducted a comprehensive bibliometric analysis. Using the Web of Science Core Collection database, we searched for English-language articles published between 1998 and 2022. Analyzing the resulting publication data, we identified trends, patterns, and research gaps. Our analysis encompassed co-authorship networks, citation analysis, and keyword co-occurrence analysis. With 8283 publications identified, averaging 331.32 publications per year, our findings highlight China, the United States, India, Japan, and Germany as the top contributing countries. The Chinese Academy of Sciences, Sun Yat-Sen University, and University of São Paulo emerged as the most productive institutions. Key themes in the literature included "cancer," "cytotoxicity," "apoptosis," "metabolites," and "fungus." Recent trends indicate increased interest in keywords such as "green synthesis," "molecular docking," "anticancer activity," "antibacterial," "anticancer," and "silver nanoparticles." Our study provides a comprehensive assessment of the current research landscape in the field of fungi and cancer, offering insights into collaborative networks, research directions, and emerging hotspots. The growing publication rate demonstrates the rising interest in the topic, while identifying leading countries, institutions, and research themes serves as a valuable resource for researchers, policymakers, and funders interested in supporting investigations on fungi-derived compounds as potential anti-cancer agents.

Identifiants

pubmed: 37529342
doi: 10.1016/j.heliyon.2023.e18592
pii: S2405-8440(23)05800-0
pmc: PMC10388209
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e18592

Informations de copyright

© 2023 The Authors. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

Front Cell Infect Microbiol. 2023 Jan 09;12:1027448
pubmed: 36699721
Nat Microbiol. 2017 Jul 25;2:17120
pubmed: 28741610
J Prosthet Dent. 2023 Feb;129(2):323-340
pubmed: 34175112
Int J Nanomedicine. 2019 May 09;14:3427-3438
pubmed: 31190801
Planta Med. 2016 Mar;82(4):344-55
pubmed: 26848704
Sci Rep. 2022 Jul 12;12(1):11834
pubmed: 35821239
Nature. 2019 Oct;574(7777):264-267
pubmed: 31578522
Fungal Biol Biotechnol. 2022 May 25;9(1):11
pubmed: 35614515
FEMS Microbiol Rev. 2022 Mar 3;46(2):
pubmed: 34919672
Adv Wound Care (New Rochelle). 2018 Jul 1;7(7):247-255
pubmed: 29984114
J Med Virol. 2023 Jan;95(1):e27892
pubmed: 35644836
Molecules. 2022 Jan 04;27(1):
pubmed: 35011527
Nat Prod Rep. 2014 May;31(5):617-27
pubmed: 24651312
Immunology. 2021 Jan;162(1):11-16
pubmed: 32880925
Front Bioeng Biotechnol. 2019 Oct 22;7:287
pubmed: 31696113
Antioxidants (Basel). 2020 Nov 26;9(12):
pubmed: 33256101
Scientometrics. 2017;111(2):1053-1070
pubmed: 28490825
Front Oncol. 2023 Jan 12;12:1051482
pubmed: 36713550
Curr Med Chem. 2018;25(2):141-185
pubmed: 28494746
Nat Prod Res. 2023 Feb 10;:1-7
pubmed: 36772803
BMC Cancer. 2021 Sep 3;21(1):987
pubmed: 34479519
Nat Rev Immunol. 2011 Apr;11(4):275-88
pubmed: 21394104
Nat Prod Bioprospect. 2023 Jun 1;13(1):17
pubmed: 37261606
Sci Rep. 2020 Oct 30;10(1):18726
pubmed: 33127928
Front Microbiol. 2021 Apr 13;12:643639
pubmed: 33927703
Curr Oncol. 2023 Jan 29;30(2):1626-1647
pubmed: 36826086
Eur J Med Chem. 2023 Jan 15;246:114971
pubmed: 36462440
Toxicol Mech Methods. 2022 Jul;32(6):395-419
pubmed: 34930097
J Clin Oncol. 2018 Oct 20;36(30):3043-3054
pubmed: 30179565
Int J Mol Sci. 2023 Mar 14;24(6):
pubmed: 36982610
Drug Discov Today. 2022 Feb;27(2):547-557
pubmed: 34655796
Biomed Pharmacother. 2023 Apr;160:114332
pubmed: 36736282
Cancers (Basel). 2021 Jun 24;13(13):
pubmed: 34202433
Cancer Lett. 2018 Feb 28;415:40-48
pubmed: 29197615
Cell Death Dis. 2014 May 08;5:e1212
pubmed: 24810048
Int J Infect Dis. 2023 Feb;127:23-25
pubmed: 36462573
Appl Biochem Biotechnol. 2022 Jul;194(7):3296-3319
pubmed: 35349089
Antibiotics (Basel). 2023 Mar 16;12(3):
pubmed: 36978464
PLoS Negl Trop Dis. 2020 Feb 20;14(2):e0007964
pubmed: 32078635
J Fungi (Basel). 2022 Mar 10;8(3):
pubmed: 35330287
Environ Sci Pollut Res Int. 2022 Jul;29(32):48908-48925
pubmed: 35201581
Nat Prod Res. 2022 Nov;36(22):5701-5707
pubmed: 34905421
Antibiotics (Basel). 2023 Mar 13;12(3):
pubmed: 36978433
Environ Res. 2022 May 15;208:112721
pubmed: 35031337
Nat Commun. 2021 Dec 1;12(1):7014
pubmed: 34853306
Cancers (Basel). 2023 Jan 12;15(2):
pubmed: 36672439
Sci Rep. 2021 May 14;11(1):10356
pubmed: 33990673
Nutrients. 2022 Aug 30;14(17):
pubmed: 36079840
Scientometrics. 2010 Aug;84(2):523-538
pubmed: 20585380
Nat Med. 2022 Oct 6;:
pubmed: 36203061
Front Microbiol. 2021 Jun 14;12:650177
pubmed: 34194402
Lancet Infect Dis. 2017 Nov;17(11):e367-e377
pubmed: 28774696
Front Chem. 2021 Nov 19;9:755351
pubmed: 34869205
Int J Oncol. 2018 Mar;52(3):1023-1032
pubmed: 29393399
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11551-11558
pubmed: 32404424
Cell. 2022 Sep 29;185(20):3807-3822.e12
pubmed: 36179671
Nat Rev Gastroenterol Hepatol. 2019 Feb;16(2):76
pubmed: 30626900
Phytochemistry. 2021 Dec;192:112967
pubmed: 34598042
Semin Immunol. 2023 Mar;66:101728
pubmed: 36841146
Mol Plant Pathol. 2019 Jun;20(6):877-892
pubmed: 30945788
Eur J Med Chem. 2020 Sep 15;202:112502
pubmed: 32652407
Sci Rep. 2018 Mar 2;8(1):3943
pubmed: 29500365
Front Bioeng Biotechnol. 2022 Oct 12;10:1026248
pubmed: 36312554
Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):
pubmed: 33876755
Org Biomol Chem. 2020 Nov 28;18(44):9035-9038
pubmed: 33135037
Br J Gen Pract. 2023 Jan 26;73(727):e133-e140
pubmed: 36702582
BMC Cancer. 2023 Mar 24;23(1):272
pubmed: 36964542
Biometals. 2023 Feb;36(1):97-109
pubmed: 36414828
Theranostics. 2022 Mar 14;12(6):2833-2859
pubmed: 35401838
Biomater Sci. 2021 Sep 7;9(17):5732-5744
pubmed: 34313267
J Zhejiang Univ Sci B. 2023 Mar 15;24(3):275-280
pubmed: 36916003
Appl Biochem Biotechnol. 2023 Jul;195(7):4011-4035
pubmed: 36652091
J Fungi (Basel). 2022 Jan 27;8(2):
pubmed: 35205880
Environ Sci Pollut Res Int. 2019 May;26(13):13649-13657
pubmed: 30919178
Front Pharmacol. 2022 Jul 13;13:925387
pubmed: 35910346
Crit Rev Biotechnol. 2018 Sep;38(6):817-835
pubmed: 29254388
Molecules. 2021 May 10;26(9):
pubmed: 34068647
Med Mycol. 2018 Apr 1;56(suppl_1):165-187
pubmed: 29538732
J Fungi (Basel). 2023 Mar 21;9(3):
pubmed: 36983549
Cell. 2022 Sep 29;185(20):3789-3806.e17
pubmed: 36179670
Appl Biochem Biotechnol. 2023 Feb 28;:
pubmed: 36853440
Front Public Health. 2023 Jan 30;11:1039782
pubmed: 36794064
Curr Probl Cardiol. 2023 Mar;48(3):101537
pubmed: 36529228
J Appl Microbiol. 2020 Jun;128(6):1634-1646
pubmed: 31954094
Metabolites. 2023 Jan 21;13(2):
pubmed: 36837781
Chin Med J (Engl). 2022 Feb 9;135(5):584-590
pubmed: 35143424
Proc Natl Acad Sci U S A. 2004 Apr 6;101 Suppl 1:5303-10
pubmed: 14724295
Mar Drugs. 2019 Mar 20;17(3):
pubmed: 30897716
J Fungi (Basel). 2023 Mar 05;9(3):
pubmed: 36983490
Signal Transduct Target Ther. 2023 Jan 16;8(1):35
pubmed: 36646684
Front Oncol. 2023 Jan 25;13:1078254
pubmed: 36761953
Appl Microbiol Biotechnol. 2023 Feb;107(4):1077-1093
pubmed: 36648526
Biology (Basel). 2021 May 27;10(6):
pubmed: 34071886
Colloids Surf B Biointerfaces. 2006 Feb 1;47(2):160-4
pubmed: 16420977
Nat Rev Cancer. 2019 Dec;19(12):665
pubmed: 31616076
Biomed Pharmacother. 2020 Oct;130:110550
pubmed: 32739740
Nanomaterials (Basel). 2022 Dec 28;13(1):
pubmed: 36616058
Expert Rev Anti Infect Ther. 2023 Apr;21(4):355-363
pubmed: 36786717
Planta Med. 2020 Sep;86(13-14):976-982
pubmed: 32018306
Immunity. 2019 Jul 16;51(1):27-41
pubmed: 31315034
Org Biomol Chem. 2020 Jan 28;18(4):642-645
pubmed: 31916553
CA Cancer J Clin. 2023 Jan;73(1):17-48
pubmed: 36633525
Photodermatol Photoimmunol Photomed. 2023 Jul;39(4):373-383
pubmed: 36810775
Front Pharmacol. 2021 Apr 26;12:542891
pubmed: 33981211
Clin Transl Radiat Oncol. 2022 Dec 05;39:100556
pubmed: 36545362
Phytochemistry. 2023 Sep;213:113765
pubmed: 37330031
Bioinorg Chem Appl. 2022 Sep 26;2022:3142674
pubmed: 36199747
J Fungi (Basel). 2023 Feb 28;9(3):
pubmed: 36983477
Toxins (Basel). 2022 Jul 29;14(8):
pubmed: 36006179
Curr Res Pharmacol Drug Discov. 2021 Sep 01;2:100050
pubmed: 34909676
Cell Signal. 2023 Jun;106:110592
pubmed: 36641081
Cold Spring Harb Perspect Med. 2014 Sep 02;4(9):a019778
pubmed: 25183855
Phytomedicine. 2019 Aug;61:152830
pubmed: 31048125
Phytochemistry. 2023 Aug;212:113743
pubmed: 37269936
Clin Exp Med. 2023 Feb 11;:
pubmed: 36773211
Int J Mol Sci. 2023 May 02;24(9):
pubmed: 37175852
Int J Mol Sci. 2021 Jul 23;22(15):
pubmed: 34360643
Healthcare (Basel). 2023 Jan 19;11(3):
pubmed: 36766879
ACS Omega. 2022 Dec 07;7(50):46653-46673
pubmed: 36570288
Arch Microbiol. 2023 Jan 10;205(2):61
pubmed: 36625985
Mar Drugs. 2023 Mar 04;21(3):
pubmed: 36976215
Microorganisms. 2023 Jan 01;11(1):
pubmed: 36677409
Nat Rev Cancer. 2022 Dec;22(12):659
pubmed: 36323799

Auteurs

Jiawei Xu (J)

Department of Breast Surgery, Affiliated Cancer Hospital of Nanchang University, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, 330029, China.

Ying Zeng (Y)

Affiliated People Hospital of Nanchang University, Nanchang 330000, China.

Chengdong Yu (C)

Department of Breast Surgery, Affiliated Cancer Hospital of Nanchang University, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, 330029, China.

Siyi Xu (S)

Department of Breast Surgery, Affiliated Cancer Hospital of Nanchang University, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, 330029, China.

Lei Tang (L)

Department of Breast Surgery, Affiliated Cancer Hospital of Nanchang University, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, 330029, China.

Xiaoqiang Zeng (X)

Department of Breast Surgery, Affiliated Cancer Hospital of Nanchang University, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, 330029, China.

Yanxiao Huang (Y)

Department of Breast Surgery, Affiliated Cancer Hospital of Nanchang University, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, 330029, China.

Zhengkui Sun (Z)

Department of Breast Surgery, Affiliated Cancer Hospital of Nanchang University, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, 330029, China.

Bin Xu (B)

Jiangxi Health Committee Key (JHCK) Laboratory of Tumor Metastasis, Jiangxi Cancer Hospital, Nanchang 330029, Jiangxi, China.

Tenghua Yu (T)

Department of Breast Surgery, Affiliated Cancer Hospital of Nanchang University, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Jiangxi Clinical Research Center for Cancer, 330029, China.

Classifications MeSH